In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jody Hatcher, CEO of Morris & ...

Will Robinson, program director, LogiPharma, reveals why the conference will be moved to Vienna moving forward.

Exploring the importance of contract development and manufacturing organizations in advancing the latest technology for ...

In recent times, AI has become the talk of the town for its potential applications in every sector, including logistics. When ...

Respective industry and government agendas could significantly reshape the US prescription drug market.

In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Rachel Thorpe, executive director at ...

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Chris O’Dell, Turquoise Health’s SVP of market solutions, discusses the biggest challenges healthcare ...

When delays and disruptions threaten not only product integrity but patient well-being, thorough risk assessment and mitigation are essential.

Steffen Lang, president, operations, executive committee member, Novartis, discusses what to expect from Novartis over the next decade in terms of technological innovations.

Keeping that in mind, LogiPharma Europe wanted to find ways to remedy that challenge, and welcomed a panel discussion on “Future-Proofing for Complex Novel Modalities: How Can You Deliver Personalized ...

By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and ...

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jody Hatcher, CEO of Morris & Dickson ...